Work

The Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 Modulates Chronic Active BCR Signaling and Induces Tumor Regression in Relapsed/Refractory ABC DLBCL

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.2716.2716

Authors: Louis M. Staudt, Kieron Dunleavy, Joseph J. Buggy, Eric Hedrick, Nicole Lucas, Stefania Pittaluga, Sameer Jhavar, Roland Schmitz, Mickey Williams, Jason Lih, Elaine S. Jaffe, Wyndham H. Wilson

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Pharmacyclics (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2573155364

FWCI: 4.926

Cites: 6

Cited by: 27

Related to: 10